Results 31 to 40 of about 68,822 (222)

Using haloperidol as an anti-emetic in palliative care: informing practice through evidence from cancer treatment and post-operative contexts [PDF]

open access: yes, 2013
YesNausea and vomiting are common symptoms in palliative care. Haloperidol is often used as an antiemetic in this context, although direct evidence supporting this practice is limited.
Alison Blenkinsopp   +27 more
core   +1 more source

Pipamperone and delirium: a preliminary evaluation of its effectiveness in the management of delirium and its subtypes

open access: yesSwiss Medical Weekly, 2017
INTRODUCTION Delirium has been recognised as an underdiagnosed and undermanaged syndrome with substantial prevalence rates and potentially deleterious consequences in the medically ill population.
Soenke Boettger   +6 more
doaj   +1 more source

Establishing gold standard approaches to rapid tranquillisation: a review and discussion of the evidence on the safety and efficacy of medications currently used [PDF]

open access: yes, 2008
Background: Rapid tranquillisation is used when control of agitation, aggression or excitement is required. Throughout the UK there is no consensus over the choice of drugs to be used as first line treatment.
Branford, David   +5 more
core   +1 more source

Haloperidol Induced Cell Cycle Arrest and Apoptosis in Glioblastoma Cells

open access: yesBiomedicines, 2020
Although several antipsychotic drugs have been shown to possess anticancer activities, haloperidol, a “first-generation” antipsychotic drug, has not been extensively evaluated for potential antineoplastic properties.
Fotios Papadopoulos   +9 more
doaj   +1 more source

Fluphenazine decanoate (depot) and enanthate for schizophrenia [PDF]

open access: yes, 2015
Background: Intramuscular injections (depot preparations) offer an advantage over oral medication for treating schizophrenia by reducing poor compliance.
Abuzzahab   +336 more
core   +1 more source

Effects of Tandospirone, a 5-HT1A Agonistic Anxiolytic Agent, on Haloperidol-Induced Catalepsy and Forebrain Fos Expression in Mice

open access: yesJournal of Pharmacological Sciences, 2009
We studied the effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice. Haloperidol (0.5 mg/kg, i.p.) markedly increased the catalepsy time and enhanced Fos expression in the ...
Yukihiro Ohno, Saki Shimizu, Junta Imaki
doaj   +1 more source

Cataleptogenic Effect of Haloperidol Formulated in Water-Soluble Calixarene-Based Nanoparticles

open access: yesPharmaceutics, 2023
In this study, a water-soluble form of haloperidol was obtained by coaggregation with calix[4]resorcinol bearing viologen groups on the upper rim and decyl chains on the lower rim to form vesicular nanoparticles.
Nadezda E. Kashapova   +8 more
doaj   +1 more source

Cannabinoid Hyperemesis Syndrome [PDF]

open access: yes, 2015
Legalization of marijuana use will increase the number of people who will become long-term users. A prior medical record review study in Australia, in 2004, identified 19 chronic marijuana users who entered the emergency department with recurrent ...
Heise, Lynn
core   +2 more sources

Automated identification of Fos expression [PDF]

open access: yes, 2001
The concentration of Fos, a protein encoded by the immediate-early gene c-fos, provides a measure of synaptic activity that may not parallel the electrical activity of neurons.
Cherkerzian, S.   +7 more
core   +1 more source

Two Sudden and Unexpected Deaths of Patients with Schizophrenia Associated with Intramuscular Injections of Antipsychotics and Practice Guidelines to Limit the Use of High Doses of Intramuscular Antipsychotics

open access: yesCase Reports in Psychiatry, 2016
Intravenous haloperidol has been associated with torsades de pointes (TdP). These two sudden deaths were probable adverse drug reactions (ADRs) following intramuscular (IM) antipsychotics.
Nasratullah Wahidi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy